121 related articles for article (PubMed ID: 24316476)
21. Active targeting of dendritic cells with mannan-decorated PLGA nanoparticles.
Ghotbi Z; Haddadi A; Hamdy S; Hung RW; Samuel J; Lavasanifar A
J Drug Target; 2011 May; 19(4):281-92. PubMed ID: 20590403
[TBL] [Abstract][Full Text] [Related]
22. Surface modification of poly(D,L-lactic-co-glycolic acid) nanoparticles with protamine enhanced cross-presentation of encapsulated ovalbumin by bone marrow-derived dendritic cells.
Han R; Zhu J; Yang X; Xu H
J Biomed Mater Res A; 2011 Jan; 96(1):142-9. PubMed ID: 21105162
[TBL] [Abstract][Full Text] [Related]
23. Multifunctional poly(D,L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer.
Sun B; Ranganathan B; Feng SS
Biomaterials; 2008 Feb; 29(4):475-86. PubMed ID: 17953985
[TBL] [Abstract][Full Text] [Related]
24. Improved therapeutic effect of folate-decorated PLGA-PEG nanoparticles for endometrial carcinoma.
Liang C; Yang Y; Ling Y; Huang Y; Li T; Li X
Bioorg Med Chem; 2011 Jul; 19(13):4057-66. PubMed ID: 21641806
[TBL] [Abstract][Full Text] [Related]
25. Targeted Polymeric Nanoparticles for Brain Delivery of High Molecular Weight Molecules in Lysosomal Storage Disorders.
Salvalaio M; Rigon L; Belletti D; D'Avanzo F; Pederzoli F; Ruozi B; Marin O; Vandelli MA; Forni F; Scarpa M; Tomanin R; Tosi G
PLoS One; 2016; 11(5):e0156452. PubMed ID: 27228099
[TBL] [Abstract][Full Text] [Related]
26. Targeting nevirapine delivery across human brain microvascular endothelial cells using transferrin-grafted poly(lactide-co-glycolide) nanoparticles.
Kuo YC; Lin PI; Wang CC
Nanomedicine (Lond); 2011 Aug; 6(6):1011-26. PubMed ID: 21707298
[TBL] [Abstract][Full Text] [Related]
27. Exploiting Bacterial Pathways for BBB Crossing with PLGA Nanoparticles Modified with a Mutated Form of Diphtheria Toxin (CRM197): In Vivo Experiments.
Tosi G; Vilella A; Veratti P; Belletti D; Pederzoli F; Ruozi B; Vandelli MA; Zoli M; Forni F
Mol Pharm; 2015 Oct; 12(10):3672-84. PubMed ID: 26312414
[TBL] [Abstract][Full Text] [Related]
28. Intracellular drug delivery in Leishmania-infected macrophages: Evaluation of saponin-loaded PLGA nanoparticles.
Van de Ven H; Vermeersch M; Vandenbroucke RE; Matheeussen A; Apers S; Weyenberg W; De Smedt SC; Cos P; Maes L; Ludwig A
J Drug Target; 2012 Feb; 20(2):142-54. PubMed ID: 22080813
[TBL] [Abstract][Full Text] [Related]
29. Clathrin and caveolin-1 expression in primary pigmented rabbit conjunctival epithelial cells: role in PLGA nanoparticle endocytosis.
Qaddoumi MG; Gukasyan HJ; Davda J; Labhasetwar V; Kim KJ; Lee VH
Mol Vis; 2003 Oct; 9():559-68. PubMed ID: 14566223
[TBL] [Abstract][Full Text] [Related]
30. Application of Polymeric Nanoparticles for CNS Targeted Zinc Delivery In Vivo.
Chhabra R; Ruozi B; Vilella A; Belletti D; Mangus K; Pfaender S; Sarowar T; Boeckers TM; Zoli M; Forni F; Vandelli MA; Tosi G; Grabrucker AM
CNS Neurol Disord Drug Targets; 2015; 14(8):1041-53. PubMed ID: 26295815
[TBL] [Abstract][Full Text] [Related]
31. Brain iron homeostasis.
Moos T
Dan Med Bull; 2002 Nov; 49(4):279-301. PubMed ID: 12553165
[TBL] [Abstract][Full Text] [Related]
32. Nanoparticulate drug carriers based on hybrid poly(D,L-lactide-co-glycolide)-dendron structures.
Costantino L; Gandolfi F; Bossy-Nobs L; Tosi G; Gurny R; Rivasi F; Vandelli MA; Forni F
Biomaterials; 2006 Sep; 27(26):4635-45. PubMed ID: 16716395
[TBL] [Abstract][Full Text] [Related]
33. Augmented anticancer efficacy of doxorubicin-loaded polymeric nanoparticles after oral administration in a breast cancer induced animal model.
Jain AK; Swarnakar NK; Das M; Godugu C; Singh RP; Rao PR; Jain S
Mol Pharm; 2011 Aug; 8(4):1140-51. PubMed ID: 21557558
[TBL] [Abstract][Full Text] [Related]
34. Induction of oxidative stress, lysosome activation and autophagy by nanoparticles in human brain-derived endothelial cells.
Halamoda Kenzaoui B; Chapuis Bernasconi C; Guney-Ayra S; Juillerat-Jeanneret L
Biochem J; 2012 Feb; 441(3):813-21. PubMed ID: 22026563
[TBL] [Abstract][Full Text] [Related]
35. Enhanced electrostatic interaction between chitosan-modified PLGA nanoparticle and tumor.
Yang R; Shim WS; Cui FD; Cheng G; Han X; Jin QR; Kim DD; Chung SJ; Shim CK
Int J Pharm; 2009 Apr; 371(1-2):142-7. PubMed ID: 19118614
[TBL] [Abstract][Full Text] [Related]
36. Poly(D,L-lactide-co-glycolide acid) nanoparticles for DNA delivery: waiving preparation complexity and increasing efficiency.
Gvili K; Benny O; Danino D; Machluf M
Biopolymers; 2007 Apr 5-15; 85(5-6):379-91. PubMed ID: 17266128
[TBL] [Abstract][Full Text] [Related]
37. Transport of saquinavir across human brain-microvascular endothelial cells by poly(lactide-co-glycolide) nanoparticles with surface poly-(γ-glutamic acid).
Kuo YC; Yu HW
Int J Pharm; 2011 Sep; 416(1):365-75. PubMed ID: 21736932
[TBL] [Abstract][Full Text] [Related]
38. Chitosan-coated PLGA nanoparticles: a sustained drug release strategy for cell cultures.
Chronopoulou L; Massimi M; Giardi MF; Cametti C; Devirgiliis LC; Dentini M; Palocci C
Colloids Surf B Biointerfaces; 2013 Mar; 103():310-7. PubMed ID: 23261553
[TBL] [Abstract][Full Text] [Related]
39. Accelerating thrombolysis with chitosan-coated plasminogen activators encapsulated in poly-(lactide-co-glycolide) (PLGA) nanoparticles.
Chung TW; Wang SS; Tsai WJ
Biomaterials; 2008 Jan; 29(2):228-37. PubMed ID: 17953984
[TBL] [Abstract][Full Text] [Related]
40. Surface coverage of didecyl dimethylammonium bromide on poly(lactide-co-glycolide) nanoparticles.
Kuo YC; Yu HW
Colloids Surf B Biointerfaces; 2011 May; 84(1):253-8. PubMed ID: 21288700
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
